Published in Curr Infect Dis Rep on August 01, 2000
Toxoplasmosis: a global threat. J Glob Infect Dis (2011) 1.19
Diagnosis of cerebral toxoplasmosis in AIDS patients in Brazil: importance of molecular and immunological methods using peripheral blood samples. J Clin Microbiol (2005) 1.11
Host Cell Preference of Toxoplasma gondii Cysts in Murine Brain: A Confocal Study. J Neuroparasitology (2010) 1.08
PCR assay using cerebrospinal fluid for diagnosis of cerebral toxoplasmosis in Brazilian AIDS patients. J Clin Microbiol (2004) 1.00
Frequency of Toxoplasma gondii in HIV Positive Patients from West of Iran by ELISA and PCR. Iran J Parasitol (2015) 0.95
A surge in the seroprevalence of toxoplasmosis among the residents of islands in Gangwha-gun, Incheon, Korea. Korean J Parasitol (2012) 0.94
HIV Protease Inhibitors: Effect on the Opportunistic Protozoan Parasites. Open Med Chem J (2011) 0.87
Therapy and prophylaxis of opportunistic infections in HIV-infected patients: a guideline by the German and Austrian AIDS societies (DAIG/ÖAG) (AWMF 055/066). Infection (2013) 0.78
Brain biopsy in AIDS patients: diagnostic yield and treatment applications. AIDS Res Ther (2014) 0.77
Toxoplasma gondii: localization of purine nucleoside phosphorylase activity in vitro and in vivo by electron microscopy. Med Mol Morphol (2005) 0.77
Seroprevalence of Toxoplasmosis Detected by RDT in Residents near the DMZ (demilitarized zone) of Cheorwon-gun, Gangwon-do, Korea. Korean J Parasitol (2017) 0.75
Toxoplasmic encephalitis in AIDS. Clin Infect Dis (1992) 7.64
Toxoplasmosis of the central nervous system in the acquired immunodeficiency syndrome. N Engl J Med (1992) 6.30
Toxoplasmic encephalitis in patients with the acquired immunodeficiency syndrome. Members of the ACTG 077p/ANRS 009 Study Team. N Engl J Med (1993) 2.55
A prospective study of criteria for the diagnosis of toxoplasmic encephalitis in 186 AIDS patients. The BIOTOXO Study Group. AIDS (1997) 2.21
1999 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus. U.S. Public Health Service (USPHS) and Infectious Diseases Society of America (IDSA). MMWR Recomm Rep (1999) 2.15
Rapid prenatal diagnosis of congenital Toxoplasma infection by using polymerase chain reaction and amniotic fluid. J Clin Microbiol (1990) 1.95
PET scanning and the human immunodeficiency virus-positive patient. J Nucl Med (1997) 1.83
Prevalence of Toxoplasma infection in a cohort of homosexual men at risk of AIDS and toxoplasmic encephalitis. J Acquir Immune Defic Syndr (1993) 1.67
Identification of Toxoplasma gondii infections by BI gene amplification. J Clin Microbiol (1991) 1.48
Aerosolized pentamidine, cotrimoxazole and dapsone-pyrimethamine for primary prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitis. AIDS (1995) 1.47
Detection of Toxoplasma gondii by PCR and tissue culture in cerebrospinal fluid and blood of human immunodeficiency virus-seropositive patients. J Clin Microbiol (1995) 1.39
Dapsone-pyrimethamine compared with aerosolized pentamidine as primary prophylaxis against Pneumocystis carinii pneumonia and toxoplasmosis in HIV infection. The PRIO Study Group. N Engl J Med (1993) 1.35
Trovafloxacin is active against Toxoplasma gondii. Antimicrob Agents Chemother (1996) 1.32
Diagnosis of AIDS-related focal brain lesions: a decision-making analysis based on clinical and neuroradiologic characteristics combined with polymerase chain reaction assays in CSF. Neurology (1997) 1.31
Cats and toxoplasmosis risk in HIV-infected adults. JAMA (1993) 1.28
Analysis of aqueous humor in ocular toxoplasmosis. N Engl J Med (1991) 1.24
Neuroimaging of AIDS. I. Central nervous system toxoplasmosis. Neuroimaging Clin N Am (1997) 1.16
Randomized trial of trimethoprim-sulfamethoxazole versus pyrimethamine-sulfadiazine for therapy of toxoplasmic encephalitis in patients with AIDS. Italian Collaborative Study Group. Antimicrob Agents Chemother (1998) 1.09
Polymerase chain reaction for Toxoplasma gondii DNA in the cerebrospinal fluid of AIDS patients with focal brain lesions. AIDS (1994) 1.06
Pyrimethamine-clarithromycin combination for therapy of acute Toxoplasma encephalitis in patients with AIDS. Antimicrob Agents Chemother (1991) 1.06
Atovaquone for salvage treatment and suppression of toxoplasmic encephalitis in patients with AIDS. Atovaquone/Toxoplasmic Encephalitis Study Group. Clin Infect Dis (1997) 1.01
Diagnosis of cerebral toxoplasmosis in association with AIDS using the polymerase chain reaction. Scand J Infect Dis (1990) 0.97
Selection and characterization of Toxoplasma gondii mutants resistant to artemisinin. J Infect Dis (1998) 0.93
Comparison of high and low doses of trimethoprim-sulfamethoxazole for primary prevention of toxoplasmic encephalitis in human immunodeficiency virus-infected patients. Clin Infect Dis (1999) 0.89
Preventing toxoplasmic encephalitis in persons infected with human immunodeficiency virus. Clin Infect Dis (1995) 0.89
Penetration of clindamycin and its metabolite N-demethylclindamycin into cerebrospinal fluid following intravenous infusion of clindamycin phosphate in patients with AIDS. Antimicrob Agents Chemother (1998) 0.88
Synergistic effect of clindamycin and atovaquone in acute murine toxoplasmosis. Antimicrob Agents Chemother (1999) 0.87
Diagnosis of toxoplasmic encephalitis in HIV-infected patients. AIDS (1997) 0.84
Evaluation of different techniques in the diagnosis of Toxoplasma encephalitis. J Med Microbiol (1997) 0.83
In vitro evaluation of the activities of azithromycin alone and combined with pyrimethamine against Toxoplasma gondii. Antimicrob Agents Chemother (1993) 0.83
Brain lesions in patients with acquired immunodeficiency syndrome. Arch Intern Med (1989) 0.82
Changing disease patterns in focal brain lesion-causing disorders in AIDS. J Acquir Immune Defic Syndr Hum Retrovirol (1998) 0.79
Paclitaxel arrests growth of intracellular Toxoplasma gondii. Antimicrob Agents Chemother (1998) 0.79
Quinupristin-dalfopristin is active against Toxoplasma gondii. Antimicrob Agents Chemother (1999) 0.78
Effects of early separation on the dairy cow and calf. 1. Separation at 6 h, 1 day and 4 days after birth. Appl Anim Behav Sci (2000) 0.89
A novel RU486 inducible system for the activation and repression of genes. Adv Drug Deliv Rev (1998) 0.88
Correlation of endoscopic and histologic findings before and after treatment for nasopharyngeal carcinoma Head Neck (2001) 0.80
A novel series of copolymers containing 2,5-dicyano-1,4-phenylene-vinylene--synthetic tuning of the HOMO and LUMO energy levels of conjugated polymers Chemistry (2000) 0.77